Olivier Danos

RGNX

Olivier Danos serves as Chief Scientific Officer at REGENXBIO Inc. (RGNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$44.0K

Net Position

Net Seller

$44.0K

Companies Traded

RGNX

Active Period

Feb 2025

1 total trades

Most Recent

Sell RGNX

Feb 1, 2025 · $44.0K

Olivier Danos's Insider Trading at REGENXBIO Inc. (RGNX)

Buys

0 · $0.00

Sells

1 · $44.0K

Total Shares Bought

Total Shares Sold

5,452

RGNX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 1, 2025	Sell	5,452	$8.07	$44.0K	0

Related Insiders

PAKOLA STEVE

officer: Chief Medical Officer

RGNXSell · May 13, 2026

Patrick J. Christmas

Chief Strategy & Legal Officer

RGNXSell · Feb 1, 2026

Kenneth T. Mills

Director

RGNXSell · Jan 27, 2026

Craig Malzahn

Chief Technology Officer

RGNXSell · Jan 2, 2026

Curran Simpson

Chief Executive Officer

RGNXSell · Jan 2, 2026

Mitchell Chan

Chief Financial Officer

RGNXSell · Sep 1, 2025

Explore More Insider Trading Data

RGNX Insider Trading Activity

View all insider trades at REGENXBIO Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity